GlaxoSmithKline has been granted a European marketing licence for its key treatment for depression. Wellbutrin was approved by US regulators in 2003 and has treated 13 million patients with major depressive disorder.
From: www.redorbit.com
GSK Wins Euro Licence for Drug ; Business News IN BRIEF
Posted by Ruslan Abuzant at 3:12 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment